Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery

  • Serrano-Villar, Sergio
  • Sánchez-Carrillo, Sergio
  • Talavera-Rodríguez, Alba
  • Lelouvier, Benjamin
  • Gutiérrez, Carolina
  • Vallejo, Alejandro
  • Servant, Florence
  • Bernadino, José I.
  • Estrada, Vicente
  • Madrid, Nadia
  • Gosalbes, María José
  • Bisbal, Otilia
  • de-Lagarde, María
  • Martínez-Sanz,Javier
  • Ron, Raquel
  • Herrera, Sabina
  • Moreno, Santiago
  • Ferrer, Manuel
[EN] Human immunodeficiency virus (HIV) infection impairs mucosal immunity and leads to bacterial translocation, fueling chronic inflammation and disease progression. While this is well established, questions remain about the compositional profile of the translocated bacteria, and to what extent it is influenced by antiretroviral therapy (ART). Using 16S ribosomal DNA targeted sequencing and shotgun proteomics, we showed that HIV increases bacterial translocation from the gut to the blood. HIV increased alpha diversity in the blood, which was dominated by aerobic bacteria belonging to Micrococcaceae (Actinobacteria) and Pseudomonadaceae (Proteobacteria) families, and the number of circulating bacterial proteins was also increased. Forty-eight weeks of ART attenuated this phenomenon. We found that enrichment with Lactobacillales order, and depletion of Actinobacteria class and Moraxellaceae and Corynebacteriacae families, were significantly associated with greater immune recovery and correlated with several inflammatory markers. Our findings suggest that the molecular cross talk between the host and the translocated bacterial products could influence ART-mediated immune recovery., This work was supported by the Instituto de Salud Carlos III (Plan Estatal de I+D+i 2013–2016, projects PI15/00345 and PI18/00154); the Fundación Asociación Española Contra el Cáncer within the European Research Era-NET aligning national/regional translational cancer research programs and activities program (grant AC17/00019) and cofinanced by the European Development Regional Fund; and Plan Estatal de I+D+i 2013–2016 (grant PT17/0019 to the Proteomics Facility of the Spanish National Center for BIotechnology).